MedTrace Logo

Building Recovery By Improving Goals, Habits, and Thoughts

NCT01191788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 299

Last updated 2022-10-18

Study results available
· View outcomes & findings →

Summary

The investigators will investigate whether group Cognitive Behavioral Therapy (CBT) for depression, with alcohol and other drug (AOD) treatment counselors leading the groups, is effective and cost effective in treating depression. If so, it could substantially increase access to appropriate mental health care. 360 clients with Beck Depression Inventory-II scores \> 17 who are being treated in a single public sector AOD treatment organization will receive one of two conditions: (1) usual care residential AOD treatment (UC); (2) usual care AOD residential treatment plus a 16-session course of group CBT delivered by trained AOD counselors (CBT). Data will be analyzed using an intent-to-treat model. The investigators will collect data on the service-level costs and health effects associated with UC and CBT, and will calculate the incremental cost per unit of depression and AOD improvement, compared to UC.

Conditions

Interventions

BEHAVIORAL

Group Cognitive Behavioral Therapy

16 two hour sessions of group CBT

BEHAVIORAL

Group CBT for Depression

16 of group CBT for depression delivered in 2 hour groups for up to 8 weeks by a trained substance abuse treatment counselor

Sponsors & Collaborators

  • Behavioral Health Services, Inc.

    collaborator INDUSTRY

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • RAND

    lead OTHER

Principal Investigators

  • Katherine Watkins, MD, MSHS · RAND

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2009-07-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01191788 on ClinicalTrials.gov